One of the most formidable challenges facing start-ups – indeed, facing the drug development community as a whole – is how to translate a promising scientific approach into a therapy that's not only safe and effective but easy to use. Over the past 10 days, Antegrin Therapeutics LLC showed that it may have checked that important box.